The FDA label includes a boxed warning regarding thyroid C-cell tumors observed in rodent studies, with contraindications for patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Semaglutide is a GLP-1 receptor agonist that helps people lose weight by: Activating the brains appetite centers to reduce hunger and food cravings
Semaglutide GLP-1 has been shown to significantly reduce body weight, improve blood sugar control, and reduce waist circumference
Insulin Secretion Insulin, a hormone, helps cells absorb glucose to store energy
Studied doses typically range from 900 to 1,500 mg daily, divided into two or three doses to minimize gastrointestinal side effects, though it's important to note that berberine has poor and variable oral bioavailability
Cloudiness indicates microbial contamination, particulate formation, or protein aggregation